Literature DB >> 2384191

Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II.

T J Orchard1, J S Dorman, R E Maser, D J Becker, A L Drash, D Ellis, R E LaPorte, L H Kuller.   

Abstract

The prevalence of and interrelationships among all four major complications of insulin-dependent diabetes mellitus (IDDM) and their risk factors are being examined in a large epidemiologic study of IDDM subjects diagnosed in childhood. This article focuses on the baseline prevalence of complications in the 657 subjects diagnosed between 1950 and 1980 and currently aged 8-48 yr, with a mean duration of 20 yr. In addition to background retinopathy being virtually universal after 20 yr of diabetes, proliferative retinopathy affects 70% of IDDM subjects after 30 yr duration. As with overt nephropathy, prevalence of proliferative retinopathy is marginally higher in females than in males at short durations; the previously reported male excess is limited to the subjects with IDDM of longer duration (greater than or equal to 25 yr). Somewhat different patterns of microalbuminuria are also seen by sex. Males show a threefold increase in prevalence from 10 to 25 yr duration, whereas females show a more constant prevalence across these durations. A further rise in microalbuminuria is seen in males but not females at greater than or equal to 30 yr duration, giving a combined prevalence of microalbuminuria and overt nephropathy at greater than or equal to 30 yr duration of 84% (males) and 59% (females). Distal symmetrical polyneuropathy shows a constant rise with duration and is only marginally higher in men. Prevalence of cardiovascular (coronary and cerebral) disease shows no sex difference, whereas peripheral vascular disease is particularly common in women after 30 yr duration (greater than 30%) compared with men (11%) when determined by ankle/arm blood pressure ratio less than 0.8 at rest or after exercise.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2384191     DOI: 10.2337/diab.39.9.1116

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  147 in total

1.  Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study.

Authors:  M Nordwall; M Bojestig; H J Arnqvist; J Ludvigsson
Journal:  Diabetologia       Date:  2004-07-02       Impact factor: 10.122

2.  Microalbuminuria.

Authors:  P H Winocour
Journal:  BMJ       Date:  1992-05-09

Review 3.  Microvascular disease in children and adolescents with type 1 diabetes and obesity.

Authors:  M Loredana Marcovecchio; Francesco Chiarelli
Journal:  Pediatr Nephrol       Date:  2010-08-19       Impact factor: 3.714

Review 4.  Anti-fibrosis therapy and diabetic nephropathy.

Authors:  Anil Karihaloo
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

5.  Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications.

Authors:  Timothy M Hughes; Christopher M Ryan; Howard J Aizenstein; Karen Nunley; Peter J Gianaros; Rachel Miller; Tina Costacou; Elsa S Strotmeyer; Trevor J Orchard; Caterina Rosano
Journal:  J Diabetes Complications       Date:  2013-08-30       Impact factor: 2.852

6.  Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration.

Authors:  Katherine V Williams; Dorothy J Becker; Trevor J Orchard; Tina Costacou
Journal:  J Diabetes Complications       Date:  2019-05-31       Impact factor: 2.852

7.  Progression of coronary artery calcium in type 1 diabetes mellitus.

Authors:  Tina Costacou; Daniel Edmundowicz; Catherine Prince; Baqiyyah Conway; Trevor J Orchard
Journal:  Am J Cardiol       Date:  2007-09-27       Impact factor: 2.778

Review 8.  Sex, diabetes and the kidney.

Authors:  Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

9.  Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule.

Authors:  Y Vergouwe; S S Soedamah-Muthu; J Zgibor; N Chaturvedi; C Forsblom; J K Snell-Bergeon; D M Maahs; P-H Groop; M Rewers; T J Orchard; J H Fuller; K G M Moons
Journal:  Diabetologia       Date:  2009-11-04       Impact factor: 10.122

10.  Prediction of proliferative diabetic retinopathy with hemoglobin level.

Authors:  Baqiyyah N Conway; Rachel G Miller; Ronald Klein; Trevor J Orchard
Journal:  Arch Ophthalmol       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.